In today’s episode, we explore the mailbag — in particular, your YouTube comments.

The Z-drugs: Ambien. Lunesta. Sonata. What are these? Can they cause dependence?

Are benzos effective for treating anxiety? Insomnia? Seizures? If they aren’t safe, what is the evidence? How many BIND symptoms are there? Could these be permanent? And what about COVID? Tune in for the surprising answers. In today’s episode, we ask some key questions about benzos and provide real answers, with evidence to back them. We also share questions from our international listeners on CBD and probiotics, and we hear a powerful story of one woman’s struggle with her t

On February 24th, 1960, the very first benzodiazepine was approved in the U.S. 60 years later, they are still some of the most popular drugs on the planet. Join us as we explore the history of some of the world’s most fabled, and vilified drugs. In today’s episode, we look back at the past 60 years of benzodiazepines and hope that through knowledge we can finally learn from our past. We also have a benzo story from Florida, discuss the variations of mindful movement practices

Our mission is to make evidence-based improvements to the prescribing of benzodiazepines and Z-drugs. The Alliance for Benzodiazepine Best Practices’ primary objective is to significantly reduce the number of benzodiazepine withdrawal sufferers by reducing the number of new prescriptions for benzodiazepines and Z-drugs, limit the duration of use, and provide an evidence-based pathway for deprescribing. Our focus is to illustrate the problems associated with benzodiazepines, i

We seek to break the stigma and raise awareness around prescribed benzodiazepine injury; provide a voice to the patients who are suffering, and facilitate research and access to competent, evidence-based medical care for those impacted by benzodiazepine-induced disability. We are a group of patients and medical professionals who believe the over-prescription of benzodiazepines without proper warning has resulted in a growing national epidemic of benzodiazepine injury. While w

The Associated Press reported yesterday that between 2002 and 2007 the CIA investigated the use of benzos, in particular, midazolam (Versed), in the interrogation of terror suspects. In a recently declassified report provided to the American Civil Liberties Union (ACLU), details of this drug research program were revealed. Versed was considered possibly worth a trial if unequivocal legal sanction first were obtained. There were at least two legal obstacles: a prohibition agai